Navigation Links
Neuracel Aims to Reduce Peripheral Neuropathy Pain
Date:5/21/2013

Boise, Idaho (PRWEB) May 21, 2013

The American Diabetes Association (http://goo.gl/YRSF1) states that almost 26 million people in the United States of America are affected with peripheral neuropathy. Needless to say, diabetic patients are at a great risk of developing peripheral neuropathy which unfortunately makes it harder for them to lead normal lives. The ADA further goes on saying that the disease usually affects people aged more than 20 years and around 2 million new cases are diagnosed every year in the States.

Detrimental Effects of Peripheral Neuropathy

Even though no cure has yet been discovered for diabetic patients yet, a lot of treatments are available in the markets to help relieve pain and make the lives of patients easier. The debilitating effects of peripheral neuropathy have their toll on normal living which makes even walking about independently a difficult task. The nervous system is greatly damaged which disrupts blood flow to the lower body. Paralysis is also a threat to some patients. In extreme cases, amputations might also become necessary to save the lives of neuropathy patients. Treatments ensure that blood flow remains normal, the over sensitive skin of patients is no longer susceptible to injury, and also that the nervous system is somewhat put back into its functional condition.

About Neuracel

Among the many treatments for peripheral neuropathy available in the markets, Neuracel is one of the few that boasts completely natural ingredients. This ultimate treatment guarantees long-term results instead of just short-term pain relief. It also works towards actually reversing the damaging effects of the disease. For diabetic patients who have not yet developed neuropathy, Neuracel aims to help keep it at bay forever. The medication comes in different deals for those who wish to save money on bulk buying disc
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Neuracel Launches An All New Organic Treatment for Peripheral Neuropathy
2. Neuracel Hits the Market - Aims To Provide A Natural Remedy For Diabetic Peripheral Neuropathy
3. Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy
4. Peripheral Neuropathy Naturally Treatable Through Neuracel's Ultimate Neuropathy Support System
5. Huntingtons Disease Linked to Reduced Cancer Risk in Study
6. BMC study shows diverting passengers to elevators could help reduce falls at Logan Airport
7. Decision guide reduced uncertainty over breast cancer prevention, study finds
8. Scoliosis Treatment Might Reduce Need for Surgeries
9. Exercise helps smokers to quit smoking, to remain smoke-free and to reduce the risk of death
10. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
11. Groundbreaking Nigeria summit results in major commitment to reduce child deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... LTW Cyber is an innovation hub for technology ... of addressing the needs of the global market for ... to grow while seeking collaborative opportunities with the other ... in LTW Cyber focus on secure application security, grounded ... and analyzing open source. As the hub matures, ...
(Date:3/27/2015)... March 27, 2015 The federal court ... allege the statin medication increases the risk that a ... Inc.’s Motion to Dismiss four individual cases that had ... Management Order issued in the U.S. District Court, District ... that the dismissals were warranted because the plaintiffs in ...
(Date:3/27/2015)... California (PRWEB) March 27, 2015 ... Entertainment’s EcoLuxe Lounge in the Stardust Penthouse on ... Debbie Durkin, Los Angeles’ leading sustainable product TV ... behind this unforgettable day-long event, which featured some ... and ecologically sound products and services. , “We ...
(Date:3/27/2015)... According to a recently published report series ... screw market in Europe is in decline due to ... segment. Price decreases are being seen across the entire ... the total European trauma device market, continued pricing pressure ... year after year. , “Such price drops are ...
(Date:3/27/2015)... According to Health Day , on March 6th, ... (NAS) are causing alarm for Florida officials. Infants born ... a month of their lives- and can experience seizures, ... condition is precipitated by drug use during pregnancy. Unfortunately, ... medically assisted drug treatment) will also inflict NAS on ...
Breaking Medicine News(10 mins):Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3Health News:Choices Recovery Releases 'Salute to the Oscars' EcoLuxe Lounge Compilation Video 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 3Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2
... , MONDAY, March 7 (HealthDay News) -- Sleep tight, but ... message of a new survey that suggests many Americans might ... bedtime in front of the electronic glow of a television, ... exposure to bright light before bed disrupts sleep. But some ...
... , MONDAY, March 7 (HealthDay News) -- Genetics ... -- where fear and stress are a fact of daily ... decline, new research warns. The culprit is a specific ... that while this gene is known to play a key ...
... , MONDAY, March 7 (HealthDay News) -- Young adults ... less likely to achieve the same level of education ... Improved medical care over the past 40 years has ... surviving into adulthood. However, they carry the burden of ...
... less treatment in the American health care system than their ... dose of empathy helps close racial gaps in pain treatment. ... ease the pain of members of their own race in ... at the University of Wisconsin-Madison. "I want to be ...
... identified a critical part of the process by which ... childhood infections, respiratory syncytial virus, causes disease. ... for RSV, which in 2005 was estimated to have ... among children under five worldwide. By analyzing samples ...
... tumor growth, and naturally mounts an anti-cancer defense. Dendritic ... present them to T cells, and those "primed" T ... cells. In recent years, researchers have attempted to capitalize ... namely, by generating a pool of tumor antigen-pulsed DCs ...
Cached Medicine News:Health News:Using Electronics Before Bed May Hamper Sleep 2Health News:Using Electronics Before Bed May Hamper Sleep 3Health News:Mix of Genetics and Stress Can Impair Mental Abilities 2Health News:Surviving Serious Childhood Illness Takes Toll Later: Study 2Health News:Surviving Serious Childhood Illness Takes Toll Later: Study 3Health News:New perspective diminishes racial bias in pain treatment 2Health News:Scientists find key mechanism of childhood respiratory disease 2Health News:Scientists find key mechanism of childhood respiratory disease 3
(Date:3/26/2015)... -- Huntington Memorial Hospital is the first facility in ... replacement (TAVR), a minimally invasive replacement of heart valves. ... replace an aortic valve without a chest incision or ... The procedure is performed by a dedicated Huntington Hospital ... , MD, interventional cardiologist and Robbin Cohen , ...
(Date:3/26/2015)... March 26, 2015  OncoGenex Pharmaceuticals, Inc. (NASDAQ: ... clinical developments and announced fourth quarter and year ... Developments and Anticipated Near-term MilestonesCustirsen , ... to negotiate the termination of their collaboration and ... final termination agreement are ongoing. , Two ...
(Date:3/26/2015)... According to a new market research report ... Cryoablation, Others), Department (Interventional Radiology, Surgery, Oncology), Application (Liver ... Forecasts to 2019", published by MarketsandMarkets, the Tumor Ablation ... at a CAGR of 11.50% by 2019. ... through 195 pages and in-depth TOC on "Tumor Ablation ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8Tumor Ablation Market Worth $462.0 Million by 2019 2Tumor Ablation Market Worth $462.0 Million by 2019 3Tumor Ablation Market Worth $462.0 Million by 2019 4
... that it will report its 2010 year-end earnings on Thursday, April ... an analyst and investor call at 9:00 AM EDT live via ... in the conference call within the U.S. and Canada, dial (866) ... (708) 290-1340. The conference ID is 58484489. ...
... Boston Scientific Corporation (NYSE: BSX ... (FDA) approval and launch of the ION™ Paclitaxel-Eluting ... drug-eluting stent technology.  The ION Stent System incorporates ... for coronary stenting and intended to improve the ...
Cached Medicine Technology:Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 2Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 3Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 4Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 5
Light weight adjustable trial frame, adult...
Classic Trial Frames UB3 that has long set the standard....
Non Sterile surgical blade....
BD Beaver Cataract blade, 30.0 mm long x 2.2 mm wide, designed for ICCE and ECCE procedures, designed for ICCE and ECCE, sterile....
Medicine Products: